Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine

Multiple myeloma is an incurable malignant plasma cell disease characterized by survival ranging from several months to more than 15 years. Assessment of risk and underlying molecular heterogeneity can be excellently done by gene expression profiling (GEP), but its way into clinical routine is hampe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 2011-12, Vol.17 (23), p.7240-7247
Hauptverfasser:	MEISSNER, Tobias, SECKINGER, Anja, REME, Thierry, HIELSCHER, Thomas, MÖHLER, Thomas, NEBEN, Kai, GOLDSCHMIDT, Hartmut, KLEIN, Bernard, HOSE, Dirk
Format:	Artikel
Sprache:	eng
Schlagworte:	Algorithms Antineoplastic agents Biological and medical sciences Chromosome Aberrations Data Interpretation, Statistical Gene Expression Profiling Gene Expression Regulation, Neoplastic Hematologic and hematopoietic diseases Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Microarray Analysis Multiple Myeloma - genetics Multiple Myeloma - mortality Multiple Myeloma - pathology Oligonucleotide Array Sequence Analysis Pharmacology. Drug treatments Prognosis Software
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!